California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on August 12, 2026

Aug. 12, 2026

Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Aug. 12, 2026

Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Aligos Therapeutics Announces First Participant Dosed in the Phase 1 Study of its Potentially Best-in-Class Antisense Oligonucleotide ALG-170675 by its Partner Amoytop in China

Indeterminate GlobeNewswire

Aug. 12, 2026

MaxCyte Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 12, 2026

RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth

Indeterminate GlobeNewswire

Aug. 12, 2026

BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results

Indeterminate GlobeNewswire

Aug. 12, 2026

BioStem Technologies Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 12, 2026

Kura Oncology Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 12, 2026

Acquisition of Own Shares

Indeterminate GlobeNewswire

Aug. 12, 2026

Inkoop van eigen aandelen

Indeterminate GlobeNewswire

Aug. 12, 2026

Hyperion DeFi Reports 2Q 2026 Financial Results with Another Record Quarterly Net Income and Strong Operating Momentum

Indeterminate GlobeNewswire

Aug. 12, 2026

ArriVent BioPharma Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 12, 2026

Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 12, 2026

Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire

Aug. 12, 2026

Outlook Therapeutics Announces Proposed Public Offering of Common Stock and Warrants

Indeterminate GlobeNewswire

Aug. 12, 2026

Sangamo Therapeutics Selects Successful Bidders Following Competitive Asset Auction for $163.55 Million in Cash Consideration at Closing and Up to $100 Million in Potential Milestones

Indeterminate GlobeNewswire

Aug. 12, 2026

Earth Science Tech, Inc. (ETST) Expands National Footprint with Strategic Acquisition of California Compounding Pharmacy, Meduvo LLC

Indeterminate GlobeNewswire